nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—FGFR2—Thalidomide—leprosy	0.334	0.597	CbGbCtD
Sunitinib—ABCC2—Rifampicin—leprosy	0.0406	0.0726	CbGbCtD
Sunitinib—CYP3A7—Rifampicin—leprosy	0.0271	0.0485	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.0271	0.0485	CbGbCtD
Sunitinib—CYP3A7—Dapsone—leprosy	0.0224	0.04	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0224	0.04	CbGbCtD
Sunitinib—CYP3A5—Thalidomide—leprosy	0.021	0.0375	CbGbCtD
Sunitinib—CYP3A5—Rifampicin—leprosy	0.0203	0.0363	CbGbCtD
Sunitinib—CYP3A5—Dapsone—leprosy	0.0168	0.03	CbGbCtD
Sunitinib—ABCB1—Rifampicin—leprosy	0.0132	0.0237	CbGbCtD
Sunitinib—CYP3A4—Rifampicin—leprosy	0.00793	0.0142	CbGbCtD
Sunitinib—CYP3A4—Dapsone—leprosy	0.00655	0.0117	CbGbCtD
Sunitinib—Hypoalbuminaemia—Dapsone—leprosy	0.00642	0.0516	CcSEcCtD
Sunitinib—Phosphorus low—Thalidomide—leprosy	0.00622	0.05	CcSEcCtD
Sunitinib—Blood phosphorus decreased—Thalidomide—leprosy	0.00494	0.0397	CcSEcCtD
Sunitinib—Posterior reversible encephalopathy syndrome—Thalidomide—leprosy	0.00437	0.0351	CcSEcCtD
Sunitinib—Nephrotic syndrome—Dapsone—leprosy	0.0029	0.0233	CcSEcCtD
Sunitinib—Gastrointestinal perforation—Thalidomide—leprosy	0.00275	0.0221	CcSEcCtD
Sunitinib—Thromboembolic event—Thalidomide—leprosy	0.00266	0.0214	CcSEcCtD
Sunitinib—Tumour lysis syndrome—Thalidomide—leprosy	0.00258	0.0208	CcSEcCtD
Sunitinib—Lipase increased—Thalidomide—leprosy	0.00244	0.0196	CcSEcCtD
Sunitinib—Septic shock—Thalidomide—leprosy	0.00238	0.0191	CcSEcCtD
Sunitinib—OXSR1—Menadione—Thalidomide—leprosy	0.00187	0.448	CbGdCrCtD
Sunitinib—Intestinal perforation—Thalidomide—leprosy	0.00181	0.0146	CcSEcCtD
Sunitinib—Proteinuria—Dapsone—leprosy	0.00159	0.0128	CcSEcCtD
Sunitinib—Protein urine present—Dapsone—leprosy	0.00157	0.0126	CcSEcCtD
Sunitinib—Raised liver function tests—Thalidomide—leprosy	0.00155	0.0125	CcSEcCtD
Sunitinib—Aphthous stomatitis—Thalidomide—leprosy	0.00153	0.0123	CcSEcCtD
Sunitinib—RPS6KA1—Menadione—Thalidomide—leprosy	0.00148	0.356	CbGdCrCtD
Sunitinib—White blood cell count decreased—Thalidomide—leprosy	0.00144	0.0116	CcSEcCtD
Sunitinib—Transient ischaemic attack—Thalidomide—leprosy	0.00142	0.0114	CcSEcCtD
Sunitinib—Lymphopenia—Thalidomide—leprosy	0.0014	0.0113	CcSEcCtD
Sunitinib—Skin exfoliation—Dapsone—leprosy	0.00134	0.0107	CcSEcCtD
Sunitinib—Platelet count decreased—Thalidomide—leprosy	0.00121	0.00969	CcSEcCtD
Sunitinib—Febrile neutropenia—Thalidomide—leprosy	0.00119	0.00958	CcSEcCtD
Sunitinib—Deep vein thrombosis—Thalidomide—leprosy	0.00118	0.00947	CcSEcCtD
Sunitinib—Oral candidiasis—Thalidomide—leprosy	0.00113	0.00907	CcSEcCtD
Sunitinib—Hypothyroidism—Thalidomide—leprosy	0.00112	0.00898	CcSEcCtD
Sunitinib—Embolism—Thalidomide—leprosy	0.00112	0.00898	CcSEcCtD
Sunitinib—Nail disorder—Thalidomide—leprosy	0.00111	0.00888	CcSEcCtD
Sunitinib—Hypercalcaemia—Thalidomide—leprosy	0.00103	0.00829	CcSEcCtD
Sunitinib—Thrombosis—Thalidomide—leprosy	0.00101	0.00814	CcSEcCtD
Sunitinib—Metrorrhagia—Thalidomide—leprosy	0.001	0.00807	CcSEcCtD
Sunitinib—Pleural effusion—Thalidomide—leprosy	0.000937	0.00752	CcSEcCtD
Sunitinib—Hyperaesthesia—Thalidomide—leprosy	0.000914	0.00734	CcSEcCtD
Sunitinib—Nasopharyngitis—Dapsone—leprosy	0.00091	0.00731	CcSEcCtD
Sunitinib—Muscular weakness—Dapsone—leprosy	0.000897	0.00721	CcSEcCtD
Sunitinib—Myocardial ischaemia—Thalidomide—leprosy	0.000892	0.00717	CcSEcCtD
Sunitinib—Endocrine disorder—Thalidomide—leprosy	0.000865	0.00695	CcSEcCtD
Sunitinib—Pancreatitis—Dapsone—leprosy	0.000862	0.00692	CcSEcCtD
Sunitinib—Blood disorder—Thalidomide—leprosy	0.000859	0.0069	CcSEcCtD
Sunitinib—Acne—Thalidomide—leprosy	0.000852	0.00685	CcSEcCtD
Sunitinib—PLK4—Menadione—Thalidomide—leprosy	0.000822	0.197	CbGdCrCtD
Sunitinib—Proteinuria—Thalidomide—leprosy	0.000816	0.00656	CcSEcCtD
Sunitinib—Protein urine present—Thalidomide—leprosy	0.000805	0.00647	CcSEcCtD
Sunitinib—Viral infection—Thalidomide—leprosy	0.000794	0.00638	CcSEcCtD
Sunitinib—Skin discolouration—Thalidomide—leprosy	0.000794	0.00638	CcSEcCtD
Sunitinib—Cellulitis—Thalidomide—leprosy	0.000789	0.00634	CcSEcCtD
Sunitinib—Hypocalcaemia—Thalidomide—leprosy	0.000784	0.00629	CcSEcCtD
Sunitinib—Hyperuricaemia—Thalidomide—leprosy	0.000773	0.00621	CcSEcCtD
Sunitinib—Neuropathy peripheral—Dapsone—leprosy	0.000768	0.00617	CcSEcCtD
Sunitinib—Creatinine increased—Thalidomide—leprosy	0.000754	0.00605	CcSEcCtD
Sunitinib—Bone pain—Thalidomide—leprosy	0.000749	0.00601	CcSEcCtD
Sunitinib—Blood uric acid increased—Thalidomide—leprosy	0.00073	0.00587	CcSEcCtD
Sunitinib—Phosphatase alkaline increased—Thalidomide—leprosy	0.000717	0.00576	CcSEcCtD
Sunitinib—Pulmonary embolism—Thalidomide—leprosy	0.000717	0.00576	CcSEcCtD
Sunitinib—Eructation—Thalidomide—leprosy	0.000705	0.00566	CcSEcCtD
Sunitinib—Hyperkalaemia—Thalidomide—leprosy	0.000705	0.00566	CcSEcCtD
Sunitinib—Depressed level of consciousness—Thalidomide—leprosy	0.000693	0.00556	CcSEcCtD
Sunitinib—Candida infection—Thalidomide—leprosy	0.000685	0.0055	CcSEcCtD
Sunitinib—Skin exfoliation—Thalidomide—leprosy	0.000685	0.0055	CcSEcCtD
Sunitinib—Oesophagitis—Thalidomide—leprosy	0.000655	0.00526	CcSEcCtD
Sunitinib—Rash maculo-papular—Thalidomide—leprosy	0.000652	0.00524	CcSEcCtD
Sunitinib—Pulmonary oedema—Thalidomide—leprosy	0.000638	0.00513	CcSEcCtD
Sunitinib—Sepsis—Thalidomide—leprosy	0.000622	0.005	CcSEcCtD
Sunitinib—Erythema—Dapsone—leprosy	0.000613	0.00492	CcSEcCtD
Sunitinib—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000599	0.00481	CcSEcCtD
Sunitinib—Eczema—Thalidomide—leprosy	0.000579	0.00465	CcSEcCtD
Sunitinib—Cardiac failure congestive—Thalidomide—leprosy	0.000574	0.00461	CcSEcCtD
Sunitinib—Renal failure acute—Thalidomide—leprosy	0.000564	0.00453	CcSEcCtD
Sunitinib—Dermatitis bullous—Thalidomide—leprosy	0.000545	0.00438	CcSEcCtD
Sunitinib—Cough—Dapsone—leprosy	0.000535	0.00429	CcSEcCtD
Sunitinib—Cardiac failure—Thalidomide—leprosy	0.000534	0.00429	CcSEcCtD
Sunitinib—Hypoglycaemia—Thalidomide—leprosy	0.000534	0.00429	CcSEcCtD
Sunitinib—Cerebrovascular accident—Thalidomide—leprosy	0.000531	0.00427	CcSEcCtD
Sunitinib—Hyponatraemia—Thalidomide—leprosy	0.000523	0.0042	CcSEcCtD
Sunitinib—Pain in extremity—Thalidomide—leprosy	0.000521	0.00418	CcSEcCtD
Sunitinib—Face oedema—Thalidomide—leprosy	0.000503	0.00404	CcSEcCtD
Sunitinib—Blood creatinine increased—Thalidomide—leprosy	0.000488	0.00392	CcSEcCtD
Sunitinib—Dehydration—Thalidomide—leprosy	0.000484	0.00389	CcSEcCtD
Sunitinib—Liver function test abnormal—Thalidomide—leprosy	0.000481	0.00386	CcSEcCtD
Sunitinib—Dry skin—Thalidomide—leprosy	0.000477	0.00383	CcSEcCtD
Sunitinib—Hypokalaemia—Thalidomide—leprosy	0.000474	0.00381	CcSEcCtD
Sunitinib—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000469	0.00377	CcSEcCtD
Sunitinib—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000469	0.00377	CcSEcCtD
Sunitinib—Muscular weakness—Thalidomide—leprosy	0.000459	0.00369	CcSEcCtD
Sunitinib—Alanine aminotransferase increased—Thalidomide—leprosy	0.000459	0.00369	CcSEcCtD
Sunitinib—Abdominal distension—Thalidomide—leprosy	0.000453	0.00364	CcSEcCtD
Sunitinib—Insomnia—Dapsone—leprosy	0.000452	0.00363	CcSEcCtD
Sunitinib—Dysphagia—Thalidomide—leprosy	0.00045	0.00361	CcSEcCtD
Sunitinib—Pancreatitis—Thalidomide—leprosy	0.000441	0.00354	CcSEcCtD
Sunitinib—Bronchitis—Thalidomide—leprosy	0.000433	0.00348	CcSEcCtD
Sunitinib—Pancytopenia—Thalidomide—leprosy	0.000427	0.00343	CcSEcCtD
Sunitinib—DAPK1—nervous system—leprosy	0.000427	0.00292	CbGeAlD
Sunitinib—MAP2K1—skin of body—leprosy	0.000426	0.00292	CbGeAlD
Sunitinib—CSNK2A1—tendon—leprosy	0.000425	0.00291	CbGeAlD
Sunitinib—STK11—testis—leprosy	0.000421	0.00288	CbGeAlD
Sunitinib—BRD4—testis—leprosy	0.000421	0.00288	CbGeAlD
Sunitinib—Neutropenia—Thalidomide—leprosy	0.000421	0.00338	CcSEcCtD
Sunitinib—CSNK1A1—skin of body—leprosy	0.000421	0.00288	CbGeAlD
Sunitinib—TBK1—eye—leprosy	0.000419	0.00287	CbGeAlD
Sunitinib—Upper respiratory tract infection—Thalidomide—leprosy	0.000418	0.00336	CcSEcCtD
Sunitinib—RPS6KA1—testis—leprosy	0.000417	0.00285	CbGeAlD
Sunitinib—RIOK1—testis—leprosy	0.000417	0.00285	CbGeAlD
Sunitinib—TYK2—eye—leprosy	0.000417	0.00285	CbGeAlD
Sunitinib—BRD4—nervous system—leprosy	0.000413	0.00283	CbGeAlD
Sunitinib—STK11—nervous system—leprosy	0.000413	0.00283	CbGeAlD
Sunitinib—RIOK1—nervous system—leprosy	0.000409	0.0028	CbGeAlD
Sunitinib—MARK2—testis—leprosy	0.000409	0.0028	CbGeAlD
Sunitinib—TNIK—testis—leprosy	0.000409	0.0028	CbGeAlD
Sunitinib—Gastrointestinal pain—Dapsone—leprosy	0.000409	0.00328	CcSEcCtD
Sunitinib—Weight decreased—Thalidomide—leprosy	0.000407	0.00327	CcSEcCtD
Sunitinib—Hyperglycaemia—Thalidomide—leprosy	0.000406	0.00326	CcSEcCtD
Sunitinib—SGK3—testis—leprosy	0.000405	0.00277	CbGeAlD
Sunitinib—PHKG2—tendon—leprosy	0.000405	0.00277	CbGeAlD
Sunitinib—Pneumonia—Thalidomide—leprosy	0.000404	0.00324	CcSEcCtD
Sunitinib—RPS6KB1—eye—leprosy	0.000404	0.00276	CbGeAlD
Sunitinib—STK24—tendon—leprosy	0.000403	0.00275	CbGeAlD
Sunitinib—ICK—testis—leprosy	0.000401	0.00274	CbGeAlD
Sunitinib—MARK2—nervous system—leprosy	0.000401	0.00274	CbGeAlD
Sunitinib—Infestation—Thalidomide—leprosy	0.000401	0.00322	CcSEcCtD
Sunitinib—Infestation NOS—Thalidomide—leprosy	0.000401	0.00322	CcSEcCtD
Sunitinib—Depression—Thalidomide—leprosy	0.0004	0.00321	CcSEcCtD
Sunitinib—AXL—eye—leprosy	0.000399	0.00273	CbGeAlD
Sunitinib—DAPK2—tendon—leprosy	0.000398	0.00272	CbGeAlD
Sunitinib—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000398	0.0032	CcSEcCtD
Sunitinib—SGK3—nervous system—leprosy	0.000398	0.00272	CbGeAlD
Sunitinib—Acute coronary syndrome—Thalidomide—leprosy	0.000396	0.00318	CcSEcCtD
Sunitinib—Body temperature increased—Dapsone—leprosy	0.000395	0.00317	CcSEcCtD
Sunitinib—Abdominal pain—Dapsone—leprosy	0.000395	0.00317	CcSEcCtD
Sunitinib—Renal failure—Thalidomide—leprosy	0.000394	0.00317	CcSEcCtD
Sunitinib—ICK—nervous system—leprosy	0.000394	0.00269	CbGeAlD
Sunitinib—Neuropathy peripheral—Thalidomide—leprosy	0.000393	0.00316	CcSEcCtD
Sunitinib—STK16—tendon—leprosy	0.000392	0.00268	CbGeAlD
Sunitinib—Stomatitis—Thalidomide—leprosy	0.000391	0.00314	CcSEcCtD
Sunitinib—CSNK1E—skin of body—leprosy	0.00039	0.00267	CbGeAlD
Sunitinib—HIPK2—tendon—leprosy	0.00039	0.00266	CbGeAlD
Sunitinib—HIPK3—tendon—leprosy	0.00039	0.00266	CbGeAlD
Sunitinib—CHEK2—testis—leprosy	0.000388	0.00265	CbGeAlD
Sunitinib—NUAK1—testis—leprosy	0.000388	0.00265	CbGeAlD
Sunitinib—TNK1—tendon—leprosy	0.000386	0.00264	CbGeAlD
Sunitinib—RIOK2—tendon—leprosy	0.000386	0.00264	CbGeAlD
Sunitinib—OXSR1—testis—leprosy	0.000384	0.00263	CbGeAlD
Sunitinib—SNRK—testis—leprosy	0.000384	0.00263	CbGeAlD
Sunitinib—INSR—testis—leprosy	0.000384	0.00263	CbGeAlD
Sunitinib—MAP4K1—tendon—leprosy	0.000382	0.00261	CbGeAlD
Sunitinib—FGFR2—eye—leprosy	0.000381	0.00261	CbGeAlD
Sunitinib—NUAK1—nervous system—leprosy	0.00038	0.0026	CbGeAlD
Sunitinib—Epistaxis—Thalidomide—leprosy	0.000378	0.00304	CcSEcCtD
Sunitinib—STK38—testis—leprosy	0.000378	0.00259	CbGeAlD
Sunitinib—RPS6KA2—testis—leprosy	0.000378	0.00259	CbGeAlD
Sunitinib—INSR—nervous system—leprosy	0.000377	0.00258	CbGeAlD
Sunitinib—SNRK—nervous system—leprosy	0.000377	0.00258	CbGeAlD
Sunitinib—AURKC—testis—leprosy	0.000375	0.00257	CbGeAlD
Sunitinib—MAP2K2—skin of body—leprosy	0.000375	0.00257	CbGeAlD
Sunitinib—DAPK3—tendon—leprosy	0.000374	0.00256	CbGeAlD
Sunitinib—PKN1—testis—leprosy	0.000373	0.00255	CbGeAlD
Sunitinib—CSNK1G2—testis—leprosy	0.000373	0.00255	CbGeAlD
Sunitinib—STK38—nervous system—leprosy	0.000371	0.00254	CbGeAlD
Sunitinib—RPS6KA2—nervous system—leprosy	0.000371	0.00254	CbGeAlD
Sunitinib—CLK2—tendon—leprosy	0.000371	0.00254	CbGeAlD
Sunitinib—MAP4K2—tendon—leprosy	0.000369	0.00252	CbGeAlD
Sunitinib—AURKC—nervous system—leprosy	0.000368	0.00252	CbGeAlD
Sunitinib—PRPF4—testis—leprosy	0.000367	0.00251	CbGeAlD
Sunitinib—Bradycardia—Thalidomide—leprosy	0.000367	0.00295	CcSEcCtD
Sunitinib—CSNK1G2—nervous system—leprosy	0.000366	0.0025	CbGeAlD
Sunitinib—PKN1—nervous system—leprosy	0.000366	0.0025	CbGeAlD
Sunitinib—STK3—tendon—leprosy	0.000364	0.00249	CbGeAlD
Sunitinib—TYK2—skin of body—leprosy	0.000362	0.00248	CbGeAlD
Sunitinib—PRPF4B—testis—leprosy	0.000362	0.00247	CbGeAlD
Sunitinib—PRPF4—nervous system—leprosy	0.00036	0.00246	CbGeAlD
Sunitinib—Hepatitis—Thalidomide—leprosy	0.00036	0.00289	CcSEcCtD
Sunitinib—Hypoaesthesia—Thalidomide—leprosy	0.000358	0.00288	CcSEcCtD
Sunitinib—STK39—testis—leprosy	0.000357	0.00244	CbGeAlD
Sunitinib—Urinary tract disorder—Thalidomide—leprosy	0.000356	0.00286	CcSEcCtD
Sunitinib—PRPF4B—nervous system—leprosy	0.000355	0.00243	CbGeAlD
Sunitinib—Oedema peripheral—Thalidomide—leprosy	0.000355	0.00285	CcSEcCtD
Sunitinib—FLT1—eye—leprosy	0.000353	0.00242	CbGeAlD
Sunitinib—Urethral disorder—Thalidomide—leprosy	0.000353	0.00284	CcSEcCtD
Sunitinib—CSNK2A1—testis—leprosy	0.000352	0.00241	CbGeAlD
Sunitinib—STK39—nervous system—leprosy	0.00035	0.0024	CbGeAlD
Sunitinib—MYLK—testis—leprosy	0.000348	0.00238	CbGeAlD
Sunitinib—AXL—skin of body—leprosy	0.000348	0.00238	CbGeAlD
Sunitinib—CSNK2A1—nervous system—leprosy	0.000346	0.00236	CbGeAlD
Sunitinib—PLK4—testis—leprosy	0.000343	0.00235	CbGeAlD
Sunitinib—MERTK—tendon—leprosy	0.000342	0.00234	CbGeAlD
Sunitinib—STK4—testis—leprosy	0.000341	0.00233	CbGeAlD
Sunitinib—MYLK—nervous system—leprosy	0.000341	0.00233	CbGeAlD
Sunitinib—Erythema multiforme—Thalidomide—leprosy	0.000341	0.00274	CcSEcCtD
Sunitinib—YES1—eye—leprosy	0.000337	0.00231	CbGeAlD
Sunitinib—Eye disorder—Thalidomide—leprosy	0.000337	0.0027	CcSEcCtD
Sunitinib—MAP4K4—tendon—leprosy	0.000336	0.0023	CbGeAlD
Sunitinib—PHKG2—testis—leprosy	0.000335	0.00229	CbGeAlD
Sunitinib—STK4—nervous system—leprosy	0.000335	0.00229	CbGeAlD
Sunitinib—Cardiac disorder—Thalidomide—leprosy	0.000334	0.00269	CcSEcCtD
Sunitinib—STK24—testis—leprosy	0.000333	0.00228	CbGeAlD
Sunitinib—TAOK3—eye—leprosy	0.000333	0.00228	CbGeAlD
Sunitinib—FGFR2—skin of body—leprosy	0.000332	0.00227	CbGeAlD
Sunitinib—MAP3K12—tendon—leprosy	0.000331	0.00227	CbGeAlD
Sunitinib—JAK2—skin of body—leprosy	0.00033	0.00226	CbGeAlD
Sunitinib—DAPK2—testis—leprosy	0.00033	0.00225	CbGeAlD
Sunitinib—PHKG2—nervous system—leprosy	0.000329	0.00225	CbGeAlD
Sunitinib—STK24—nervous system—leprosy	0.000327	0.00224	CbGeAlD
Sunitinib—Angiopathy—Thalidomide—leprosy	0.000327	0.00263	CcSEcCtD
Sunitinib—RPS6KA3—tendon—leprosy	0.000327	0.00223	CbGeAlD
Sunitinib—Immune system disorder—Thalidomide—leprosy	0.000325	0.00261	CcSEcCtD
Sunitinib—FYN—skin of body—leprosy	0.000325	0.00222	CbGeAlD
Sunitinib—Mediastinal disorder—Thalidomide—leprosy	0.000325	0.00261	CcSEcCtD
Sunitinib—STK16—testis—leprosy	0.000324	0.00222	CbGeAlD
Sunitinib—Chills—Thalidomide—leprosy	0.000323	0.0026	CcSEcCtD
Sunitinib—HIPK3—testis—leprosy	0.000323	0.00221	CbGeAlD
Sunitinib—HIPK2—testis—leprosy	0.000323	0.00221	CbGeAlD
Sunitinib—TYRO3—testis—leprosy	0.000323	0.00221	CbGeAlD
Sunitinib—ALK—testis—leprosy	0.000323	0.00221	CbGeAlD
Sunitinib—Arrhythmia—Thalidomide—leprosy	0.000322	0.00258	CcSEcCtD
Sunitinib—CSNK1A1—tendon—leprosy	0.00032	0.00219	CbGeAlD
Sunitinib—TNK1—testis—leprosy	0.000319	0.00218	CbGeAlD
Sunitinib—RIOK2—testis—leprosy	0.000319	0.00218	CbGeAlD
Sunitinib—Alopecia—Thalidomide—leprosy	0.000318	0.00256	CcSEcCtD
Sunitinib—STK16—nervous system—leprosy	0.000318	0.00218	CbGeAlD
Sunitinib—CLK1—tendon—leprosy	0.000318	0.00218	CbGeAlD
Sunitinib—Vomiting—Dapsone—leprosy	0.000318	0.00255	CcSEcCtD
Sunitinib—MAP3K3—skin of body—leprosy	0.000318	0.00217	CbGeAlD
Sunitinib—TYRO3—nervous system—leprosy	0.000317	0.00216	CbGeAlD
Sunitinib—ALK—nervous system—leprosy	0.000317	0.00216	CbGeAlD
Sunitinib—HIPK2—nervous system—leprosy	0.000317	0.00216	CbGeAlD
Sunitinib—MAP3K19—testis—leprosy	0.000316	0.00216	CbGeAlD
Sunitinib—MAP4K1—testis—leprosy	0.000316	0.00216	CbGeAlD
Sunitinib—Mental disorder—Thalidomide—leprosy	0.000316	0.00253	CcSEcCtD
Sunitinib—Malnutrition—Thalidomide—leprosy	0.000314	0.00252	CcSEcCtD
Sunitinib—RIOK2—nervous system—leprosy	0.000313	0.00214	CbGeAlD
Sunitinib—Headache—Dapsone—leprosy	0.000313	0.00252	CcSEcCtD
Sunitinib—BMP2K—tendon—leprosy	0.000312	0.00214	CbGeAlD
Sunitinib—CAMK2G—tendon—leprosy	0.000312	0.00214	CbGeAlD
Sunitinib—MAP3K19—nervous system—leprosy	0.00031	0.00212	CbGeAlD
Sunitinib—DAPK3—testis—leprosy	0.00031	0.00212	CbGeAlD
Sunitinib—LRRK2—tendon—leprosy	0.00031	0.00212	CbGeAlD
Sunitinib—Flatulence—Thalidomide—leprosy	0.000309	0.00248	CcSEcCtD
Sunitinib—Dysgeusia—Thalidomide—leprosy	0.000307	0.00247	CcSEcCtD
Sunitinib—CLK2—testis—leprosy	0.000307	0.0021	CbGeAlD
Sunitinib—MAP4K2—testis—leprosy	0.000306	0.00209	CbGeAlD
Sunitinib—DAPK3—nervous system—leprosy	0.000304	0.00208	CbGeAlD
Sunitinib—EPHB6—skin of body—leprosy	0.000304	0.00208	CbGeAlD
Sunitinib—Back pain—Thalidomide—leprosy	0.000303	0.00244	CcSEcCtD
Sunitinib—PTK2B—tendon—leprosy	0.000302	0.00206	CbGeAlD
Sunitinib—Muscle spasms—Thalidomide—leprosy	0.000301	0.00242	CcSEcCtD
Sunitinib—STK3—testis—leprosy	0.000301	0.00206	CbGeAlD
Sunitinib—CLK2—nervous system—leprosy	0.000301	0.00206	CbGeAlD
Sunitinib—KDR—eye—leprosy	0.000299	0.00204	CbGeAlD
Sunitinib—ROCK1—testis—leprosy	0.000298	0.00203	CbGeAlD
Sunitinib—Nausea—Dapsone—leprosy	0.000297	0.00239	CcSEcCtD
Sunitinib—CSNK1E—tendon—leprosy	0.000297	0.00203	CbGeAlD
Sunitinib—FGFR1—tendon—leprosy	0.000297	0.00203	CbGeAlD
Sunitinib—IRAK4—tendon—leprosy	0.000292	0.002	CbGeAlD
Sunitinib—ROCK1—nervous system—leprosy	0.000292	0.002	CbGeAlD
Sunitinib—CSF1R—eye—leprosy	0.000291	0.00199	CbGeAlD
Sunitinib—DYRK1A—testis—leprosy	0.00029	0.00198	CbGeAlD
Sunitinib—Anaemia—Thalidomide—leprosy	0.00029	0.00233	CcSEcCtD
Sunitinib—Angioedema—Thalidomide—leprosy	0.000287	0.0023	CcSEcCtD
Sunitinib—MAP2K2—tendon—leprosy	0.000286	0.00195	CbGeAlD
Sunitinib—ULK3—tendon—leprosy	0.000286	0.00195	CbGeAlD
Sunitinib—DYRK1A—nervous system—leprosy	0.000285	0.00195	CbGeAlD
Sunitinib—MERTK—testis—leprosy	0.000283	0.00194	CbGeAlD
Sunitinib—MAP3K7—tendon—leprosy	0.000281	0.00192	CbGeAlD
Sunitinib—Leukopenia—Thalidomide—leprosy	0.000281	0.00225	CcSEcCtD
Sunitinib—MAP4K4—testis—leprosy	0.000278	0.0019	CbGeAlD
Sunitinib—MERTK—nervous system—leprosy	0.000278	0.0019	CbGeAlD
Sunitinib—TBK1—tendon—leprosy	0.000278	0.0019	CbGeAlD
Sunitinib—NUAK2—testis—leprosy	0.000276	0.00189	CbGeAlD
Sunitinib—TYK2—tendon—leprosy	0.000276	0.00189	CbGeAlD
Sunitinib—FLT3—testis—leprosy	0.000274	0.00188	CbGeAlD
Sunitinib—MAP3K12—testis—leprosy	0.000274	0.00188	CbGeAlD
Sunitinib—Cough—Thalidomide—leprosy	0.000274	0.0022	CcSEcCtD
Sunitinib—MAP4K4—nervous system—leprosy	0.000273	0.00187	CbGeAlD
Sunitinib—IRAK1—tendon—leprosy	0.000272	0.00186	CbGeAlD
Sunitinib—Convulsion—Thalidomide—leprosy	0.000272	0.00218	CcSEcCtD
Sunitinib—Hypertension—Thalidomide—leprosy	0.000271	0.00217	CcSEcCtD
Sunitinib—RPS6KA3—testis—leprosy	0.000271	0.00185	CbGeAlD
Sunitinib—MAP3K12—nervous system—leprosy	0.000269	0.00184	CbGeAlD
Sunitinib—MAP2K1—testis—leprosy	0.000269	0.00184	CbGeAlD
Sunitinib—RPS6KB1—tendon—leprosy	0.000267	0.00183	CbGeAlD
Sunitinib—Myalgia—Thalidomide—leprosy	0.000267	0.00214	CcSEcCtD
Sunitinib—Arthralgia—Thalidomide—leprosy	0.000267	0.00214	CcSEcCtD
Sunitinib—Chest pain—Thalidomide—leprosy	0.000267	0.00214	CcSEcCtD
Sunitinib—RET—tendon—leprosy	0.000266	0.00182	CbGeAlD
Sunitinib—FGR—tendon—leprosy	0.000266	0.00182	CbGeAlD
Sunitinib—RPS6KA3—nervous system—leprosy	0.000265	0.00182	CbGeAlD
Sunitinib—CSNK1A1—testis—leprosy	0.000265	0.00181	CbGeAlD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000265	0.00213	CcSEcCtD
Sunitinib—AXL—tendon—leprosy	0.000265	0.00181	CbGeAlD
Sunitinib—MAP2K1—nervous system—leprosy	0.000264	0.0018	CbGeAlD
Sunitinib—CLK1—testis—leprosy	0.000264	0.0018	CbGeAlD
Sunitinib—Dry mouth—Thalidomide—leprosy	0.000261	0.0021	CcSEcCtD
Sunitinib—CSNK1A1—nervous system—leprosy	0.00026	0.00178	CbGeAlD
Sunitinib—CAMK2G—testis—leprosy	0.000259	0.00177	CbGeAlD
Sunitinib—BMP2K—testis—leprosy	0.000259	0.00177	CbGeAlD
Sunitinib—CLK1—nervous system—leprosy	0.000259	0.00177	CbGeAlD
Sunitinib—PDGFRB—eye—leprosy	0.000258	0.00177	CbGeAlD
Sunitinib—LRRK2—testis—leprosy	0.000256	0.00175	CbGeAlD
Sunitinib—Oedema—Thalidomide—leprosy	0.000256	0.00206	CcSEcCtD
Sunitinib—SLK—tendon—leprosy	0.000255	0.00174	CbGeAlD
Sunitinib—Infection—Thalidomide—leprosy	0.000254	0.00204	CcSEcCtD
Sunitinib—CAMK2G—nervous system—leprosy	0.000254	0.00174	CbGeAlD
Sunitinib—BMP2K—nervous system—leprosy	0.000254	0.00174	CbGeAlD
Sunitinib—CSF1R—skin of body—leprosy	0.000254	0.00173	CbGeAlD
Sunitinib—PRKAA1—testis—leprosy	0.000253	0.00173	CbGeAlD
Sunitinib—Shock—Thalidomide—leprosy	0.000252	0.00202	CcSEcCtD
Sunitinib—LRRK2—nervous system—leprosy	0.000252	0.00172	CbGeAlD
Sunitinib—JAK2—tendon—leprosy	0.000251	0.00172	CbGeAlD
Sunitinib—Nervous system disorder—Thalidomide—leprosy	0.000251	0.00202	CcSEcCtD
Sunitinib—Thrombocytopenia—Thalidomide—leprosy	0.000251	0.00201	CcSEcCtD
Sunitinib—PTK2B—testis—leprosy	0.00025	0.00171	CbGeAlD
Sunitinib—FLT4—testis—leprosy	0.000249	0.0017	CbGeAlD
Sunitinib—Skin disorder—Thalidomide—leprosy	0.000249	0.002	CcSEcCtD
Sunitinib—PRKAA1—nervous system—leprosy	0.000248	0.0017	CbGeAlD
Sunitinib—FYN—tendon—leprosy	0.000248	0.00169	CbGeAlD
Sunitinib—CSNK1E—testis—leprosy	0.000246	0.00168	CbGeAlD
Sunitinib—FGFR1—testis—leprosy	0.000246	0.00168	CbGeAlD
Sunitinib—PTK2B—nervous system—leprosy	0.000245	0.00168	CbGeAlD
Sunitinib—Anorexia—Thalidomide—leprosy	0.000244	0.00196	CcSEcCtD
Sunitinib—MAP3K3—tendon—leprosy	0.000242	0.00165	CbGeAlD
Sunitinib—MAP4K5—tendon—leprosy	0.000242	0.00165	CbGeAlD
Sunitinib—IRAK4—testis—leprosy	0.000242	0.00165	CbGeAlD
Sunitinib—CSNK1E—nervous system—leprosy	0.000241	0.00165	CbGeAlD
Sunitinib—IRAK4—nervous system—leprosy	0.000237	0.00162	CbGeAlD
Sunitinib—ULK3—testis—leprosy	0.000237	0.00162	CbGeAlD
Sunitinib—MAP2K2—testis—leprosy	0.000237	0.00162	CbGeAlD
Sunitinib—MAP3K2—testis—leprosy	0.000235	0.00161	CbGeAlD
Sunitinib—FLT1—tendon—leprosy	0.000234	0.0016	CbGeAlD
Sunitinib—Musculoskeletal discomfort—Thalidomide—leprosy	0.000233	0.00187	CcSEcCtD
Sunitinib—MAP3K7—testis—leprosy	0.000233	0.00159	CbGeAlD
Sunitinib—ULK3—nervous system—leprosy	0.000232	0.00159	CbGeAlD
Sunitinib—MAP2K2—nervous system—leprosy	0.000232	0.00159	CbGeAlD
Sunitinib—Insomnia—Thalidomide—leprosy	0.000231	0.00186	CcSEcCtD
Sunitinib—EPHB6—tendon—leprosy	0.000231	0.00158	CbGeAlD
Sunitinib—MAP3K2—nervous system—leprosy	0.000231	0.00158	CbGeAlD
Sunitinib—KIT—skin of body—leprosy	0.00023	0.00157	CbGeAlD
Sunitinib—TBK1—testis—leprosy	0.00023	0.00157	CbGeAlD
Sunitinib—Paraesthesia—Thalidomide—leprosy	0.00023	0.00185	CcSEcCtD
Sunitinib—TYK2—testis—leprosy	0.000228	0.00156	CbGeAlD
Sunitinib—Dyspnoea—Thalidomide—leprosy	0.000228	0.00183	CcSEcCtD
Sunitinib—TBK1—nervous system—leprosy	0.000226	0.00154	CbGeAlD
Sunitinib—IRAK1—testis—leprosy	0.000226	0.00154	CbGeAlD
Sunitinib—Dyspepsia—Thalidomide—leprosy	0.000225	0.00181	CcSEcCtD
Sunitinib—PDGFRB—skin of body—leprosy	0.000225	0.00154	CbGeAlD
Sunitinib—TYK2—nervous system—leprosy	0.000224	0.00153	CbGeAlD
Sunitinib—YES1—tendon—leprosy	0.000223	0.00153	CbGeAlD
Sunitinib—Decreased appetite—Thalidomide—leprosy	0.000222	0.00179	CcSEcCtD
Sunitinib—STK10—tendon—leprosy	0.000221	0.00151	CbGeAlD
Sunitinib—RPS6KB1—testis—leprosy	0.000221	0.00151	CbGeAlD
Sunitinib—Gastrointestinal disorder—Thalidomide—leprosy	0.000221	0.00177	CcSEcCtD
Sunitinib—Fatigue—Thalidomide—leprosy	0.000221	0.00177	CcSEcCtD
Sunitinib—TAOK3—tendon—leprosy	0.000221	0.00151	CbGeAlD
Sunitinib—FGR—testis—leprosy	0.00022	0.0015	CbGeAlD
Sunitinib—RET—testis—leprosy	0.00022	0.0015	CbGeAlD
Sunitinib—PDGFRA—tendon—leprosy	0.000219	0.0015	CbGeAlD
Sunitinib—AXL—testis—leprosy	0.000219	0.0015	CbGeAlD
Sunitinib—Pain—Thalidomide—leprosy	0.000219	0.00176	CcSEcCtD
Sunitinib—Constipation—Thalidomide—leprosy	0.000219	0.00176	CcSEcCtD
Sunitinib—RPS6KB1—nervous system—leprosy	0.000217	0.00149	CbGeAlD
Sunitinib—RET—nervous system—leprosy	0.000216	0.00148	CbGeAlD
Sunitinib—FGR—nervous system—leprosy	0.000216	0.00148	CbGeAlD
Sunitinib—AXL—nervous system—leprosy	0.000215	0.00147	CbGeAlD
Sunitinib—SLK—testis—leprosy	0.000211	0.00144	CbGeAlD
Sunitinib—Gastrointestinal pain—Thalidomide—leprosy	0.000209	0.00168	CcSEcCtD
Sunitinib—FGFR2—testis—leprosy	0.000209	0.00143	CbGeAlD
Sunitinib—JAK2—testis—leprosy	0.000208	0.00142	CbGeAlD
Sunitinib—FGFR2—nervous system—leprosy	0.000205	0.0014	CbGeAlD
Sunitinib—FYN—testis—leprosy	0.000205	0.0014	CbGeAlD
Sunitinib—JAK2—nervous system—leprosy	0.000204	0.00139	CbGeAlD
Sunitinib—Abdominal pain—Thalidomide—leprosy	0.000202	0.00163	CcSEcCtD
Sunitinib—Body temperature increased—Thalidomide—leprosy	0.000202	0.00163	CcSEcCtD
Sunitinib—FYN—nervous system—leprosy	0.000201	0.00138	CbGeAlD
Sunitinib—MAP3K3—testis—leprosy	0.0002	0.00137	CbGeAlD
Sunitinib—MAP4K5—testis—leprosy	0.0002	0.00137	CbGeAlD
Sunitinib—KDR—tendon—leprosy	0.000198	0.00135	CbGeAlD
Sunitinib—MAP2K5—tendon—leprosy	0.000198	0.00135	CbGeAlD
Sunitinib—MAP4K5—nervous system—leprosy	0.000197	0.00134	CbGeAlD
Sunitinib—MAP3K3—nervous system—leprosy	0.000197	0.00134	CbGeAlD
Sunitinib—FLT1—testis—leprosy	0.000194	0.00132	CbGeAlD
Sunitinib—CSF1R—tendon—leprosy	0.000193	0.00132	CbGeAlD
Sunitinib—EPHB6—testis—leprosy	0.000191	0.00131	CbGeAlD
Sunitinib—FLT1—nervous system—leprosy	0.00019	0.0013	CbGeAlD
Sunitinib—Hypersensitivity—Thalidomide—leprosy	0.000189	0.00151	CcSEcCtD
Sunitinib—EPHB6—nervous system—leprosy	0.000188	0.00128	CbGeAlD
Sunitinib—YES1—testis—leprosy	0.000185	0.00127	CbGeAlD
Sunitinib—Asthenia—Thalidomide—leprosy	0.000184	0.00147	CcSEcCtD
Sunitinib—STK10—testis—leprosy	0.000183	0.00125	CbGeAlD
Sunitinib—TAOK3—testis—leprosy	0.000183	0.00125	CbGeAlD
Sunitinib—YES1—nervous system—leprosy	0.000182	0.00124	CbGeAlD
Sunitinib—PDGFRA—testis—leprosy	0.000182	0.00124	CbGeAlD
Sunitinib—Pruritus—Thalidomide—leprosy	0.000181	0.00145	CcSEcCtD
Sunitinib—STK10—nervous system—leprosy	0.00018	0.00123	CbGeAlD
Sunitinib—TAOK3—nervous system—leprosy	0.000179	0.00123	CbGeAlD
Sunitinib—PDGFRA—nervous system—leprosy	0.000178	0.00122	CbGeAlD
Sunitinib—Diarrhoea—Thalidomide—leprosy	0.000175	0.00141	CcSEcCtD
Sunitinib—PDGFRB—tendon—leprosy	0.000171	0.00117	CbGeAlD
Sunitinib—Dizziness—Thalidomide—leprosy	0.000169	0.00136	CcSEcCtD
Sunitinib—MAP2K5—testis—leprosy	0.000164	0.00112	CbGeAlD
Sunitinib—KDR—testis—leprosy	0.000164	0.00112	CbGeAlD
Sunitinib—Vomiting—Thalidomide—leprosy	0.000163	0.00131	CcSEcCtD
Sunitinib—Rash—Thalidomide—leprosy	0.000161	0.0013	CcSEcCtD
Sunitinib—Dermatitis—Thalidomide—leprosy	0.000161	0.00129	CcSEcCtD
Sunitinib—KDR—nervous system—leprosy	0.000161	0.0011	CbGeAlD
Sunitinib—MAP2K5—nervous system—leprosy	0.000161	0.0011	CbGeAlD
Sunitinib—Headache—Thalidomide—leprosy	0.00016	0.00129	CcSEcCtD
Sunitinib—CSF1R—testis—leprosy	0.00016	0.00109	CbGeAlD
Sunitinib—CSF1R—nervous system—leprosy	0.000157	0.00107	CbGeAlD
Sunitinib—Nausea—Thalidomide—leprosy	0.000152	0.00122	CcSEcCtD
Sunitinib—KIT—testis—leprosy	0.000145	0.000992	CbGeAlD
Sunitinib—KIT—nervous system—leprosy	0.000142	0.000974	CbGeAlD
Sunitinib—PDGFRB—testis—leprosy	0.000142	0.000969	CbGeAlD
Sunitinib—PDGFRB—nervous system—leprosy	0.000139	0.000951	CbGeAlD
Sunitinib—ABCC4—tendon—leprosy	0.000136	0.000932	CbGeAlD
Sunitinib—ABCB1—blood vessel—leprosy	0.000135	0.00092	CbGeAlD
Sunitinib—ABCC2—tendon—leprosy	0.000132	0.000902	CbGeAlD
Sunitinib—ABCC4—testis—leprosy	0.000113	0.000772	CbGeAlD
Sunitinib—ABCC4—nervous system—leprosy	0.000111	0.000757	CbGeAlD
Sunitinib—ABCC2—testis—leprosy	0.000109	0.000747	CbGeAlD
Sunitinib—KCNH2—testis—leprosy	8.95e-05	0.000612	CbGeAlD
Sunitinib—KCNH2—nervous system—leprosy	8.79e-05	0.000601	CbGeAlD
Sunitinib—ABCG2—testis—leprosy	7.97e-05	0.000545	CbGeAlD
Sunitinib—CYP3A4—nervous system—leprosy	5.45e-05	0.000372	CbGeAlD
Sunitinib—ABCB1—testis—leprosy	3.93e-05	0.000269	CbGeAlD
Sunitinib—ABCB1—nervous system—leprosy	3.86e-05	0.000264	CbGeAlD
Sunitinib—CYP3A7—Metabolism—SDHD—leprosy	1.74e-05	0.000105	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—NOD2—leprosy	1.73e-05	0.000105	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—RIPK2—leprosy	1.73e-05	0.000105	CbGpPWpGaD
Sunitinib—KIT—Immune System—NOD2—leprosy	1.7e-05	0.000103	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—NOD2—leprosy	1.7e-05	0.000103	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—RIPK2—leprosy	1.67e-05	0.000101	CbGpPWpGaD
Sunitinib—RPS6KA3—Developmental Biology—TNF—leprosy	1.66e-05	0.0001	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—RIPK2—leprosy	1.66e-05	0.0001	CbGpPWpGaD
Sunitinib—ABCB1—Allograft Rejection—TNF—leprosy	1.65e-05	0.0001	CbGpPWpGaD
Sunitinib—RPS6KA1—Immune System—IFNG—leprosy	1.65e-05	9.99e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Immune System—IL2—leprosy	1.65e-05	9.99e-05	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—HLA-DRB1—leprosy	1.65e-05	9.99e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—RIPK2—leprosy	1.64e-05	9.92e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—TLR2—leprosy	1.64e-05	9.92e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Immune System—IL2—leprosy	1.64e-05	9.89e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—HLA-DRB1—leprosy	1.63e-05	9.85e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—NOD2—leprosy	1.62e-05	9.77e-05	CbGpPWpGaD
Sunitinib—BLK—Immune System—HLA-DRB1—leprosy	1.61e-05	9.75e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—CD40LG—leprosy	1.61e-05	9.74e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—NOD2—leprosy	1.61e-05	9.74e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling by GPCR—IL2—leprosy	1.61e-05	9.72e-05	CbGpPWpGaD
Sunitinib—FGR—Immune System—HLA-DRB1—leprosy	1.61e-05	9.72e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—RIPK2—leprosy	1.61e-05	9.71e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—RIPK2—leprosy	1.61e-05	9.71e-05	CbGpPWpGaD
Sunitinib—YES1—Hemostasis—IL2—leprosy	1.61e-05	9.71e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—RIPK2—leprosy	1.6e-05	9.68e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—TLR2—leprosy	1.6e-05	9.68e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Immune System—CD4—leprosy	1.6e-05	9.65e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—CD8A—leprosy	1.59e-05	9.63e-05	CbGpPWpGaD
Sunitinib—CSNK1G2—Signaling Pathways—IL2—leprosy	1.59e-05	9.63e-05	CbGpPWpGaD
Sunitinib—GRK1—Signaling Pathways—IL2—leprosy	1.59e-05	9.63e-05	CbGpPWpGaD
Sunitinib—YES1—Innate Immune System—CD4—leprosy	1.57e-05	9.5e-05	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—HLA-DRB1—leprosy	1.57e-05	9.49e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—RIPK2—leprosy	1.57e-05	9.46e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Disease—CD4—leprosy	1.56e-05	9.45e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—RIPK2—leprosy	1.54e-05	9.33e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—TLR2—leprosy	1.54e-05	9.33e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—RIPK2—leprosy	1.53e-05	9.28e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—TLR2—leprosy	1.53e-05	9.28e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—CD40LG—leprosy	1.53e-05	9.24e-05	CbGpPWpGaD
Sunitinib—ABCB1—Transmembrane transport of small molecules—SLC11A1—leprosy	1.52e-05	9.21e-05	CbGpPWpGaD
Sunitinib—TBK1—Immune System—IFNG—leprosy	1.52e-05	9.18e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—CD8A—leprosy	1.51e-05	9.14e-05	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—IL2—leprosy	1.51e-05	9.13e-05	CbGpPWpGaD
Sunitinib—YES1—Adaptive Immune System—CD4—leprosy	1.51e-05	9.12e-05	CbGpPWpGaD
Sunitinib—CAMK2G—Immune System—IFNG—leprosy	1.49e-05	9.01e-05	CbGpPWpGaD
Sunitinib—IRAK1—Innate Immune System—CD4—leprosy	1.49e-05	9.01e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—NOD2—leprosy	1.49e-05	8.99e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—CD40LG—leprosy	1.48e-05	8.97e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Immune System—IL2—leprosy	1.47e-05	8.88e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—RIPK2—leprosy	1.47e-05	8.87e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—CD8A—leprosy	1.47e-05	8.87e-05	CbGpPWpGaD
Sunitinib—TBK1—Immune System—CD4—leprosy	1.47e-05	8.87e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—TLR2—leprosy	1.47e-05	8.87e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—CD40LG—leprosy	1.47e-05	8.86e-05	CbGpPWpGaD
Sunitinib—ROCK1—Developmental Biology—TNF—leprosy	1.46e-05	8.84e-05	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—IFNG—leprosy	1.46e-05	8.8e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—NOD2—leprosy	1.45e-05	8.78e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—CD8A—leprosy	1.45e-05	8.76e-05	CbGpPWpGaD
Sunitinib—TYK2—Innate Immune System—CD4—leprosy	1.45e-05	8.75e-05	CbGpPWpGaD
Sunitinib—CAMK2G—Immune System—CD4—leprosy	1.44e-05	8.71e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—CD40LG—leprosy	1.44e-05	8.7e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—CD40LG—leprosy	1.44e-05	8.7e-05	CbGpPWpGaD
Sunitinib—FGFR2—Innate Immune System—CD4—leprosy	1.43e-05	8.64e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—CD8A—leprosy	1.42e-05	8.6e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—CD8A—leprosy	1.42e-05	8.6e-05	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—CD4—leprosy	1.41e-05	8.5e-05	CbGpPWpGaD
Sunitinib—KIT—Innate Immune System—CD4—leprosy	1.4e-05	8.48e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Innate Immune System—CD4—leprosy	1.4e-05	8.48e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—NOD2—leprosy	1.4e-05	8.46e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—NOD2—leprosy	1.39e-05	8.41e-05	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—IL2—leprosy	1.38e-05	8.35e-05	CbGpPWpGaD
Sunitinib—KDR—Developmental Biology—TNF—leprosy	1.37e-05	8.3e-05	CbGpPWpGaD
Sunitinib—FGFR2—Adaptive Immune System—CD4—leprosy	1.37e-05	8.29e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—CD40LG—leprosy	1.37e-05	8.26e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—CD40LG—leprosy	1.36e-05	8.23e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—RIPK2—leprosy	1.36e-05	8.22e-05	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—IFNG—leprosy	1.35e-05	8.18e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—CD8A—leprosy	1.35e-05	8.16e-05	CbGpPWpGaD
Sunitinib—TBK1—Immune System—IL2—leprosy	1.35e-05	8.16e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Adaptive Immune System—CD4—leprosy	1.35e-05	8.15e-05	CbGpPWpGaD
Sunitinib—KIT—Adaptive Immune System—CD4—leprosy	1.35e-05	8.15e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—CD8A—leprosy	1.35e-05	8.14e-05	CbGpPWpGaD
Sunitinib—FGFR1—Innate Immune System—CD4—leprosy	1.33e-05	8.05e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—NOD2—leprosy	1.33e-05	8.04e-05	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—IL2—leprosy	1.33e-05	8.04e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—CD4—leprosy	1.33e-05	8.03e-05	CbGpPWpGaD
Sunitinib—CAMK2G—Immune System—IL2—leprosy	1.32e-05	8.01e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—IFNG—leprosy	1.32e-05	7.96e-05	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—CD4—leprosy	1.31e-05	7.9e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—HLA-DRB1—leprosy	1.3e-05	7.84e-05	CbGpPWpGaD
Sunitinib—ABCC4—Hemostasis—IL2—leprosy	1.3e-05	7.84e-05	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—IL2—leprosy	1.29e-05	7.82e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—RIPK2—leprosy	1.29e-05	7.79e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—IL2—leprosy	1.28e-05	7.74e-05	CbGpPWpGaD
Sunitinib—FGFR1—Adaptive Immune System—CD4—leprosy	1.28e-05	7.73e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Adaptive Immune System—CD4—leprosy	1.28e-05	7.71e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—CD4—leprosy	1.27e-05	7.69e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—CD4—leprosy	1.26e-05	7.64e-05	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—IL2—leprosy	1.26e-05	7.64e-05	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—IL2—leprosy	1.26e-05	7.64e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—SDHD—leprosy	1.26e-05	7.61e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—CD40LG—leprosy	1.26e-05	7.6e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—RIPK2—leprosy	1.25e-05	7.57e-05	CbGpPWpGaD
Sunitinib—ROCK1—GPCR downstream signaling—IL2—leprosy	1.24e-05	7.53e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—CD8A—leprosy	1.24e-05	7.52e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—RIPK2—leprosy	1.24e-05	7.47e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—HLA-DRB1—leprosy	1.23e-05	7.44e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—CD40LG—leprosy	1.23e-05	7.42e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—CD4—leprosy	1.23e-05	7.41e-05	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—IL2—leprosy	1.22e-05	7.4e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—RIPK2—leprosy	1.21e-05	7.34e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—RIPK2—leprosy	1.21e-05	7.34e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—CD8A—leprosy	1.21e-05	7.34e-05	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—IFNG—leprosy	1.21e-05	7.3e-05	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—IL2—leprosy	1.2e-05	7.27e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—CD4—leprosy	1.2e-05	7.23e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—HLA-DRB1—leprosy	1.19e-05	7.22e-05	CbGpPWpGaD
Sunitinib—YES1—Developmental Biology—TNF—leprosy	1.19e-05	7.21e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—CD40LG—leprosy	1.18e-05	7.15e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—HLA-DRB1—leprosy	1.18e-05	7.13e-05	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—IL2—leprosy	1.18e-05	7.13e-05	CbGpPWpGaD
Sunitinib—BLK—Immune System—IFNG—leprosy	1.18e-05	7.12e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—CD40LG—leprosy	1.18e-05	7.11e-05	CbGpPWpGaD
Sunitinib—FGR—Immune System—IFNG—leprosy	1.17e-05	7.1e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—IL2—leprosy	1.17e-05	7.08e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—CD8A—leprosy	1.17e-05	7.07e-05	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—CD4—leprosy	1.17e-05	7.05e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—CD8A—leprosy	1.16e-05	7.03e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—HLA-DRB1—leprosy	1.16e-05	7e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—HLA-DRB1—leprosy	1.16e-05	7e-05	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—CD4—leprosy	1.15e-05	6.97e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—RIPK2—leprosy	1.15e-05	6.96e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—RIPK2—leprosy	1.15e-05	6.95e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—CD4—leprosy	1.15e-05	6.95e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—CD4—leprosy	1.15e-05	6.94e-05	CbGpPWpGaD
Sunitinib—BLK—Immune System—CD4—leprosy	1.14e-05	6.88e-05	CbGpPWpGaD
Sunitinib—FGR—Immune System—CD4—leprosy	1.13e-05	6.85e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—IL2—leprosy	1.13e-05	6.83e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—IL2—leprosy	1.13e-05	6.83e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—CD40LG—leprosy	1.12e-05	6.8e-05	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—IL2—leprosy	1.12e-05	6.77e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—CD8A—leprosy	1.11e-05	6.72e-05	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—CD4—leprosy	1.11e-05	6.7e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—HLA-DRB1—leprosy	1.1e-05	6.65e-05	CbGpPWpGaD
Sunitinib—TYK2—Developmental Biology—TNF—leprosy	1.1e-05	6.64e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—HLA-DRB1—leprosy	1.1e-05	6.63e-05	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—CD4—leprosy	1.1e-05	6.63e-05	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—IL2—leprosy	1.07e-05	6.48e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—IL2—leprosy	1.07e-05	6.46e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—RIPK2—leprosy	1.06e-05	6.41e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—IL2—leprosy	1.06e-05	6.39e-05	CbGpPWpGaD
Sunitinib—BLK—Immune System—IL2—leprosy	1.05e-05	6.33e-05	CbGpPWpGaD
Sunitinib—FGR—Immune System—IL2—leprosy	1.04e-05	6.31e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—RIPK2—leprosy	1.04e-05	6.26e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—HLA-DRB1—leprosy	1.01e-05	6.12e-05	CbGpPWpGaD
Sunitinib—FGFR1—Developmental Biology—TNF—leprosy	1.01e-05	6.11e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—IL2—leprosy	1.01e-05	6.09e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—RIPK2—leprosy	9.98e-06	6.03e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—RIPK2—leprosy	9.92e-06	6e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—HLA-DRB1—leprosy	9.88e-06	5.97e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—HLA-DRB1—leprosy	9.52e-06	5.76e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—SDHD—leprosy	9.5e-06	5.74e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—IL2—leprosy	9.5e-06	5.74e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—RIPK2—leprosy	9.48e-06	5.73e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—IFNG—leprosy	9.47e-06	5.73e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—HLA-DRB1—leprosy	9.47e-06	5.73e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—IL2—leprosy	9.42e-06	5.7e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Developmental Biology—TNF—leprosy	9.3e-06	5.62e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—CD4—leprosy	9.15e-06	5.53e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—HLA-DRB1—leprosy	9.05e-06	5.47e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—IFNG—leprosy	8.99e-06	5.43e-05	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—TNF—leprosy	8.75e-06	5.29e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—IFNG—leprosy	8.72e-06	5.27e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—TNF—leprosy	8.7e-06	5.26e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—CD4—leprosy	8.68e-06	5.25e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—IFNG—leprosy	8.61e-06	5.21e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—IL2—leprosy	8.48e-06	5.13e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—IFNG—leprosy	8.46e-06	5.12e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IFNG—leprosy	8.46e-06	5.12e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—CD4—leprosy	8.42e-06	5.09e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—IL2—leprosy	8.42e-06	5.09e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—CD4—leprosy	8.32e-06	5.03e-05	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—TNF—leprosy	8.32e-06	5.03e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—CD4—leprosy	8.17e-06	4.94e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—CD4—leprosy	8.17e-06	4.94e-05	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	8.16e-06	4.93e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—IL2—leprosy	8.14e-06	4.92e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IFNG—leprosy	8.03e-06	4.85e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IFNG—leprosy	8.01e-06	4.84e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—IL2—leprosy	7.98e-06	4.83e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—CD4—leprosy	7.78e-06	4.7e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—CD4—leprosy	7.75e-06	4.69e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—IL2—leprosy	7.75e-06	4.69e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—CD4—leprosy	7.74e-06	4.68e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—CD4—leprosy	7.68e-06	4.64e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—IL2—leprosy	7.66e-06	4.63e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—IL2—leprosy	7.63e-06	4.62e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—IL2—leprosy	7.57e-06	4.57e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—CD4—leprosy	7.54e-06	4.56e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—IL2—leprosy	7.52e-06	4.55e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IL2—leprosy	7.52e-06	4.55e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IFNG—leprosy	7.39e-06	4.47e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IFNG—leprosy	7.22e-06	4.36e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—IL2—leprosy	7.19e-06	4.35e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—CD4—leprosy	7.16e-06	4.33e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—CD4—leprosy	7.14e-06	4.32e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—CD4—leprosy	7.14e-06	4.32e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL2—leprosy	7.14e-06	4.31e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL2—leprosy	7.12e-06	4.3e-05	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—IL2—leprosy	7.08e-06	4.28e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—CD4—leprosy	6.97e-06	4.21e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—IFNG—leprosy	6.95e-06	4.2e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—IL2—leprosy	6.93e-06	4.19e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IFNG—leprosy	6.92e-06	4.18e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—IL2—leprosy	6.73e-06	4.07e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—CD4—leprosy	6.72e-06	4.06e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—CD4—leprosy	6.68e-06	4.04e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—IL2—leprosy	6.68e-06	4.04e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—IL2—leprosy	6.63e-06	4.01e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IFNG—leprosy	6.61e-06	4e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—CD4—leprosy	6.59e-06	3.99e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL2—leprosy	6.57e-06	3.97e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—CD4—leprosy	6.43e-06	3.89e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—IL2—leprosy	6.43e-06	3.89e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—IL2—leprosy	6.43e-06	3.89e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—IL2—leprosy	6.43e-06	3.89e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL2—leprosy	6.41e-06	3.88e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—CD4—leprosy	6.38e-06	3.86e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—IL2—leprosy	6.27e-06	3.79e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—CD4—leprosy	6.2e-06	3.75e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL2—leprosy	6.18e-06	3.74e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—CD4—leprosy	6.17e-06	3.73e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL2—leprosy	6.15e-06	3.72e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—CD4—leprosy	5.89e-06	3.56e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL2—leprosy	5.87e-06	3.55e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SDHD—leprosy	5.85e-06	3.54e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL2—leprosy	5.44e-06	3.29e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL2—leprosy	5.16e-06	3.12e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL2—leprosy	5.01e-06	3.03e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL2—leprosy	4.95e-06	2.99e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL2—leprosy	4.86e-06	2.94e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL2—leprosy	4.86e-06	2.94e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL2—leprosy	4.61e-06	2.79e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL2—leprosy	4.6e-06	2.78e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL2—leprosy	4.25e-06	2.57e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL2—leprosy	4.15e-06	2.51e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL2—leprosy	4e-06	2.42e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL2—leprosy	3.97e-06	2.4e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL2—leprosy	3.8e-06	2.3e-05	CbGpPWpGaD
